The 2017 World Medical Innovation Forum will feature the newest technologies to diagnose, treat and manage cardiovascular and cardiometabolic disease. World Forum keynoters will include the CEOs of Eli Lilly, Boston Scientific, Medtronic, Edwards Life Sciences, Bard, Abiomed, Boehringer Ingelheim, American Heart Association, GE Healthcare, Siemens Healthcare and others, including, dozens of top investors and entrepreneurs and a large number of our Harvard faculty. Moderators have included top journalists from Bloomberg, CBS, CNBC, CNN, Fox and STAT among others. They will be joined by senior health care leaders from the biotech, pharma, and investment communities, and clinicians and investigators from across our hospitals. In addition to examining the cutting-edge issues in the field, the Forum will feature presentations from emerging investigators called First Look, the Discovery Café, and the “Disruptive Dozen”—12 emerging technologies with the potential to revolutionize the selected field over the next decade.